Semaglutide/Tirzepatide/Retatrutide + AOD-9604
To layer adipocyte-level lipolysis on top of an existing weekly GLP-1/GIP agonist, chasing fat loss that doesn't depend on further appetite suppression — marketed as a "finishing phase" add-on for a stalled plateau or the last few stubborn pounds, not a starting-point protocol.
The weekly GLP-1 shot works in the brain to make you eat less.